Loading…

Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1

This study aimed to investigate the regulatory mechanism of linc00161/miR‐128/MAPK1 axis on drug resistance of ovarian cancer. Methods: the differentially expressed lncRNAs were screened based on microarray analysis. The expression of linc00161, miR‐128 and MAPK1 in ovarian cancer‐resistant tissues...

Full description

Saved in:
Bibliographic Details
Published in:Molecular carcinogenesis 2019-04, Vol.58 (4), p.577-587
Main Authors: Xu, Mei, Zhou, Kai, Wu, Yuanzhe, Wang, Li, Lu, Su
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763
cites cdi_FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763
container_end_page 587
container_issue 4
container_start_page 577
container_title Molecular carcinogenesis
container_volume 58
creator Xu, Mei
Zhou, Kai
Wu, Yuanzhe
Wang, Li
Lu, Su
description This study aimed to investigate the regulatory mechanism of linc00161/miR‐128/MAPK1 axis on drug resistance of ovarian cancer. Methods: the differentially expressed lncRNAs were screened based on microarray analysis. The expression of linc00161, miR‐128 and MAPK1 in ovarian cancer‐resistant tissues and cells was tested qRT‐PCR, whereas MAPK1 protein expression was examined via western blot in the ovarian cancer resistant cells. The targeted relationship between miR‐128 and linc00161 as well as the relationship between miR‐128 and MAPK1 were testified by Dual luciferase gene reporter assay. The influence of miR‐128 and MAPK1 on the proliferation of ovarian cancer‐resistant cells was demonstrated by CCK‐8 and colony formation assay. The effect of linc00161 on ovarian cancer was demonstrated by xenograft tumor model in vivo. Results: Linc00161 was highly expressed in ovarian cancer‐resistant tissues and SKOV3/DDP cells while the miR‐128 displayed a lower expression. Overexpression of linc00161 increased the colony formation ratio in SKOV3 cells, whereas sh‐linc00161 reduced colony formation ratio in SKOV3/DDP cells. MAPK1 was highly expressed in ovarian cancer‐resistant tissues and cells and could be regulated by linc00161 and miR‐128. The proliferation ability of SKOV3 cell was enhanced after transfected with miR‐128 inhibitor, whereas that of SKOV3/DDP cells was attenuated by miR‐128 mimics. In addition, the colony formation ratio of SKOV3 cells co‐transfected with DDP + MAPK1 + sh‐linc00161 decreased. The colony formation ratio of SKOV3/DDP cells also declined after transfected with DDP+ MAPK1. Linc00161 regulated the drug resistance of ovarian cancer via modulating microRNA‐128/MAPK1. In vivo, sh‐linc00161 inhibited the tumor growth.
doi_str_mv 10.1002/mc.22952
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2157680029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2190938732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMoWi_gE0jAjZvRXCaTZFmKN2xVRNdDbq2RudSko3TnI_iMPomprQqCqwP_-fg45wdgH6NjjBA5qc0xIZKRNdDDSIqM8DxfBz0kpMywFHwLbMf4hBDGnKFNsEURY4Ukogf80DcmLQoMg5t0lZo5C2ePDtrQTVIUfZypxjjYjmH7ooJXDTSLIEA9h3HaNhPfTGDtTWjvrvsfb--YCKgaC-vWLnSL7ah_e4V3wcZYVdHtreYOeDg7vR9cZMOb88tBf5gZmkuScUmp1sJgOsbMpHN5LnJJuVaMsJwoTSyyhWXECu4MI5pKbgqjc6dtoXhBd8DR0jsN7XPn4qysfTSuqlTj2i6WBDNeiNSaTOjhH_Sp7UKTrkuURJIKTsmvML0YY3Djchp8rcK8xKhc1F_WpvyqP6EHK2Gna2d_wO--E5AtgVdfufm_onI0WAo_AbZZi7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2190938732</pqid></control><display><type>article</type><title>Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1</title><source>Wiley</source><creator>Xu, Mei ; Zhou, Kai ; Wu, Yuanzhe ; Wang, Li ; Lu, Su</creator><creatorcontrib>Xu, Mei ; Zhou, Kai ; Wu, Yuanzhe ; Wang, Li ; Lu, Su</creatorcontrib><description>This study aimed to investigate the regulatory mechanism of linc00161/miR‐128/MAPK1 axis on drug resistance of ovarian cancer. Methods: the differentially expressed lncRNAs were screened based on microarray analysis. The expression of linc00161, miR‐128 and MAPK1 in ovarian cancer‐resistant tissues and cells was tested qRT‐PCR, whereas MAPK1 protein expression was examined via western blot in the ovarian cancer resistant cells. The targeted relationship between miR‐128 and linc00161 as well as the relationship between miR‐128 and MAPK1 were testified by Dual luciferase gene reporter assay. The influence of miR‐128 and MAPK1 on the proliferation of ovarian cancer‐resistant cells was demonstrated by CCK‐8 and colony formation assay. The effect of linc00161 on ovarian cancer was demonstrated by xenograft tumor model in vivo. Results: Linc00161 was highly expressed in ovarian cancer‐resistant tissues and SKOV3/DDP cells while the miR‐128 displayed a lower expression. Overexpression of linc00161 increased the colony formation ratio in SKOV3 cells, whereas sh‐linc00161 reduced colony formation ratio in SKOV3/DDP cells. MAPK1 was highly expressed in ovarian cancer‐resistant tissues and cells and could be regulated by linc00161 and miR‐128. The proliferation ability of SKOV3 cell was enhanced after transfected with miR‐128 inhibitor, whereas that of SKOV3/DDP cells was attenuated by miR‐128 mimics. In addition, the colony formation ratio of SKOV3 cells co‐transfected with DDP + MAPK1 + sh‐linc00161 decreased. The colony formation ratio of SKOV3/DDP cells also declined after transfected with DDP+ MAPK1. Linc00161 regulated the drug resistance of ovarian cancer via modulating microRNA‐128/MAPK1. In vivo, sh‐linc00161 inhibited the tumor growth.</description><identifier>ISSN: 0899-1987</identifier><identifier>EISSN: 1098-2744</identifier><identifier>DOI: 10.1002/mc.22952</identifier><identifier>PMID: 30556928</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cell proliferation ; Cholecystokinin ; Colonies ; DDP ; DNA microarrays ; Drug resistance ; linc00161 ; MAPK1 ; MicroRNAs ; microRNA‐128 ; miRNA ; Ovarian cancer ; Ovarian carcinoma ; Tissues ; Xenografts</subject><ispartof>Molecular carcinogenesis, 2019-04, Vol.58 (4), p.577-587</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763</citedby><cites>FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763</cites><orcidid>0000-0003-4856-449X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30556928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Mei</creatorcontrib><creatorcontrib>Zhou, Kai</creatorcontrib><creatorcontrib>Wu, Yuanzhe</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Lu, Su</creatorcontrib><title>Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1</title><title>Molecular carcinogenesis</title><addtitle>Mol Carcinog</addtitle><description>This study aimed to investigate the regulatory mechanism of linc00161/miR‐128/MAPK1 axis on drug resistance of ovarian cancer. Methods: the differentially expressed lncRNAs were screened based on microarray analysis. The expression of linc00161, miR‐128 and MAPK1 in ovarian cancer‐resistant tissues and cells was tested qRT‐PCR, whereas MAPK1 protein expression was examined via western blot in the ovarian cancer resistant cells. The targeted relationship between miR‐128 and linc00161 as well as the relationship between miR‐128 and MAPK1 were testified by Dual luciferase gene reporter assay. The influence of miR‐128 and MAPK1 on the proliferation of ovarian cancer‐resistant cells was demonstrated by CCK‐8 and colony formation assay. The effect of linc00161 on ovarian cancer was demonstrated by xenograft tumor model in vivo. Results: Linc00161 was highly expressed in ovarian cancer‐resistant tissues and SKOV3/DDP cells while the miR‐128 displayed a lower expression. Overexpression of linc00161 increased the colony formation ratio in SKOV3 cells, whereas sh‐linc00161 reduced colony formation ratio in SKOV3/DDP cells. MAPK1 was highly expressed in ovarian cancer‐resistant tissues and cells and could be regulated by linc00161 and miR‐128. The proliferation ability of SKOV3 cell was enhanced after transfected with miR‐128 inhibitor, whereas that of SKOV3/DDP cells was attenuated by miR‐128 mimics. In addition, the colony formation ratio of SKOV3 cells co‐transfected with DDP + MAPK1 + sh‐linc00161 decreased. The colony formation ratio of SKOV3/DDP cells also declined after transfected with DDP+ MAPK1. Linc00161 regulated the drug resistance of ovarian cancer via modulating microRNA‐128/MAPK1. In vivo, sh‐linc00161 inhibited the tumor growth.</description><subject>Cell proliferation</subject><subject>Cholecystokinin</subject><subject>Colonies</subject><subject>DDP</subject><subject>DNA microarrays</subject><subject>Drug resistance</subject><subject>linc00161</subject><subject>MAPK1</subject><subject>MicroRNAs</subject><subject>microRNA‐128</subject><subject>miRNA</subject><subject>Ovarian cancer</subject><subject>Ovarian carcinoma</subject><subject>Tissues</subject><subject>Xenografts</subject><issn>0899-1987</issn><issn>1098-2744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKAzEUhoMoWi_gE0jAjZvRXCaTZFmKN2xVRNdDbq2RudSko3TnI_iMPomprQqCqwP_-fg45wdgH6NjjBA5qc0xIZKRNdDDSIqM8DxfBz0kpMywFHwLbMf4hBDGnKFNsEURY4Ukogf80DcmLQoMg5t0lZo5C2ePDtrQTVIUfZypxjjYjmH7ooJXDTSLIEA9h3HaNhPfTGDtTWjvrvsfb--YCKgaC-vWLnSL7ah_e4V3wcZYVdHtreYOeDg7vR9cZMOb88tBf5gZmkuScUmp1sJgOsbMpHN5LnJJuVaMsJwoTSyyhWXECu4MI5pKbgqjc6dtoXhBd8DR0jsN7XPn4qysfTSuqlTj2i6WBDNeiNSaTOjhH_Sp7UKTrkuURJIKTsmvML0YY3Djchp8rcK8xKhc1F_WpvyqP6EHK2Gna2d_wO--E5AtgVdfufm_onI0WAo_AbZZi7g</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Xu, Mei</creator><creator>Zhou, Kai</creator><creator>Wu, Yuanzhe</creator><creator>Wang, Li</creator><creator>Lu, Su</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4856-449X</orcidid></search><sort><creationdate>201904</creationdate><title>Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1</title><author>Xu, Mei ; Zhou, Kai ; Wu, Yuanzhe ; Wang, Li ; Lu, Su</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cell proliferation</topic><topic>Cholecystokinin</topic><topic>Colonies</topic><topic>DDP</topic><topic>DNA microarrays</topic><topic>Drug resistance</topic><topic>linc00161</topic><topic>MAPK1</topic><topic>MicroRNAs</topic><topic>microRNA‐128</topic><topic>miRNA</topic><topic>Ovarian cancer</topic><topic>Ovarian carcinoma</topic><topic>Tissues</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Mei</creatorcontrib><creatorcontrib>Zhou, Kai</creatorcontrib><creatorcontrib>Wu, Yuanzhe</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Lu, Su</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular carcinogenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Mei</au><au>Zhou, Kai</au><au>Wu, Yuanzhe</au><au>Wang, Li</au><au>Lu, Su</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1</atitle><jtitle>Molecular carcinogenesis</jtitle><addtitle>Mol Carcinog</addtitle><date>2019-04</date><risdate>2019</risdate><volume>58</volume><issue>4</issue><spage>577</spage><epage>587</epage><pages>577-587</pages><issn>0899-1987</issn><eissn>1098-2744</eissn><abstract>This study aimed to investigate the regulatory mechanism of linc00161/miR‐128/MAPK1 axis on drug resistance of ovarian cancer. Methods: the differentially expressed lncRNAs were screened based on microarray analysis. The expression of linc00161, miR‐128 and MAPK1 in ovarian cancer‐resistant tissues and cells was tested qRT‐PCR, whereas MAPK1 protein expression was examined via western blot in the ovarian cancer resistant cells. The targeted relationship between miR‐128 and linc00161 as well as the relationship between miR‐128 and MAPK1 were testified by Dual luciferase gene reporter assay. The influence of miR‐128 and MAPK1 on the proliferation of ovarian cancer‐resistant cells was demonstrated by CCK‐8 and colony formation assay. The effect of linc00161 on ovarian cancer was demonstrated by xenograft tumor model in vivo. Results: Linc00161 was highly expressed in ovarian cancer‐resistant tissues and SKOV3/DDP cells while the miR‐128 displayed a lower expression. Overexpression of linc00161 increased the colony formation ratio in SKOV3 cells, whereas sh‐linc00161 reduced colony formation ratio in SKOV3/DDP cells. MAPK1 was highly expressed in ovarian cancer‐resistant tissues and cells and could be regulated by linc00161 and miR‐128. The proliferation ability of SKOV3 cell was enhanced after transfected with miR‐128 inhibitor, whereas that of SKOV3/DDP cells was attenuated by miR‐128 mimics. In addition, the colony formation ratio of SKOV3 cells co‐transfected with DDP + MAPK1 + sh‐linc00161 decreased. The colony formation ratio of SKOV3/DDP cells also declined after transfected with DDP+ MAPK1. Linc00161 regulated the drug resistance of ovarian cancer via modulating microRNA‐128/MAPK1. In vivo, sh‐linc00161 inhibited the tumor growth.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30556928</pmid><doi>10.1002/mc.22952</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-4856-449X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0899-1987
ispartof Molecular carcinogenesis, 2019-04, Vol.58 (4), p.577-587
issn 0899-1987
1098-2744
language eng
recordid cdi_proquest_miscellaneous_2157680029
source Wiley
subjects Cell proliferation
Cholecystokinin
Colonies
DDP
DNA microarrays
Drug resistance
linc00161
MAPK1
MicroRNAs
microRNA‐128
miRNA
Ovarian cancer
Ovarian carcinoma
Tissues
Xenografts
title Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A56%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Linc00161%20regulated%20the%20drug%20resistance%20of%20ovarian%20cancer%20by%20sponging%20microRNA%E2%80%90128%20and%20modulating%20MAPK1&rft.jtitle=Molecular%20carcinogenesis&rft.au=Xu,%20Mei&rft.date=2019-04&rft.volume=58&rft.issue=4&rft.spage=577&rft.epage=587&rft.pages=577-587&rft.issn=0899-1987&rft.eissn=1098-2744&rft_id=info:doi/10.1002/mc.22952&rft_dat=%3Cproquest_cross%3E2190938732%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3492-7933bb8c13f15c7507484937ba52542ab2d0d6d52d87ec52b397c6cb4ebd6a763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2190938732&rft_id=info:pmid/30556928&rfr_iscdi=true